The A. Alfred Taubman Medical Research Institute supports some of today’s most aggressive medical science researchers, all members of the University of Michigan Medical School faculty, with three-year grants that they use to fund their investigations.
These clinician-scientists and their laboratory teams are working to combat a wide array of diseases: childhood and adult cancer, neurodegentative diseases, diabetes, ALS, cardiovascular disease, obesity and many other debilitating conditions.
Scholars also serve as advocates for research by taking part in U-M efforts to educate the public about the importance of biomedical research and the need to provide support for scientific study.
Founding Taubman Scholars
The original Taubman Scholars, they continue to serve as leaders and advisers to the institute.
- Valerie P. Opipari, M.D.
- Eva L. Feldman, M.D., Ph.D., F.A.A.N.
- David J. Pinsky, M.D.
- Max S. Wicha, M.D.
Senior Taubman Scholars
Through the progress of their research and their public stewardship of the cause of medical science, these former Taubman Scholars have earned renewed funding.
- Nicholas Boulis, M.D.
- Frank C. Brosius III, M.D.
- Charles F. Burant, M.D., Ph.D.
- Arul M. Chinnaiyan, M.D., Ph.D.
- David Ginsburg, M.D.
- Theodore Lawrence, M.D., Ph.D.
The Taubman Scholars are senior level physician-researchers and thought leaders in discovery-driven science.
- John Carethers, M.D.
- Kathleen Collins, M.D., Ph.D.
- Sharlene Day, M.D.
- Thomas Gardner, M.D., M.S.
- Jack Parent, M.D.
- Henry L. Paulson, M.D., Ph.D.
- Pavan Reddy, M.D.
- Benjamin Segal, M.D.
Taubman Emerging Scholars
The Emerging Scholars Program provides support for clinician-scientists on the U-M faculty who are in the early stages of their research careers.
There is a pressing need in the scientific community to do more to support early-career researchers who are increasingly choosing to leave the laboratory due to financial pressures. We are at risk of losing the next generation of our best and brightest scientists.
The Emerging Scholars Program offers an opportunity for them to establish their credentials in order to secure traditional funding in the future. They are aggresive "high risk, high reward" scientists who already have initatied a number of human clinical trials of new therapies for disease.
- Asheesh Bedi, M.D.
- Ronald J. Buckanovich, M.D., Ph.D.
- Sung Won Choi, M.D.
- Felix Feng, M.D.
- Bradley Foerster, M.D., Ph.D
- Katherine Gallagher, M.D.
- Johann E. Gudjonsson, M.D., Ph.D.
- Lynn Henry, M.D., Ph.D.
- Alon Kahana, M.D., Ph.D.
- Brian J. Mickey, M.D., Ph.D.
- Todd Morgan, M.D.
- Erika A. Newman, M.D.
- Parag Patil, M.D., Ph.D.
- Myria Petrou, M.A., M.S., MB ChB
- Rajesh C. Rao, M.D.
- Srijan Sen, M.D., Ph.D.
- Kanakadurga Singer, M.D.
- Adam Stein, M.D.
- Scott Tomlins, M.D., Ph.D.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars publish new findings on basal cell cancer
Ophthalmologists Alon Kahana, MD, PhD and Rajesh Rao, MD are trying to pinpoint when the common cancer turns dangerous.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results